FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Biologics

Moderna Files Patent Suit Against Pfizer/BioNTech

Moderna files a patent infringement lawsuit against Pfizer/BioNTech in Massachusetts federal court over their Comirnaty Covid-19 vaccine.

latest-news-card-1
Human Drugs

2 ICH Guidances on Drug Analytical Procedures

FDA makes available two International Council for Harmonization draft guidances on drug analytical procedures.

latest-news-card-1
Medical Devices

FDA Removes N95 Respirators from Shortages List

FDA removes N95 respirators from its medical device shortage list, which it says signals that demand or projected demand for this type of face protect...

latest-news-card-1
Human Drugs

ICH Guide on Evaluating QT/QTc Interval Prolongation

FDA releases a final guidance entitled E14 and S7B Clinical and Nonclinical Evaluation of QT/QTc Interval Prolongation and Proarrhythmic Potential Qu...

latest-news-card-1
Medical Devices

Integra LifeSciences Removes CereLink Intracranial Monitors

Integra LifeSciences begins a global product removal of all CereLink intracranial pressure monitors after customer reports were received about devices...

latest-news-card-1
Human Drugs

Incytes Pemazyre OKd for Rare Blood Cancer

FDA approves an Incyte supplemental NDA for Pemazyre (pemigatinib), a selective fibroblast growth factor receptor inhibitor for treating adults with c...

latest-news-card-1
Medical Devices

Medtronic HVAD Battery Recall is Class 1

FDA says the Medtronic recall of HVAD batteries for electrical faults is Class 1.

latest-news-card-1
Human Drugs

FDA Unit Reports High State of Pharmaceutical Quality

CDERs Office of Pharmaceutical Quality issues an upbeat outlook for drug quality in its FY 2021 annual report, with data on drug manufacturing sites a...

latest-news-card-1
Human Drugs

Novartis Suspends Dosing in Branapalm Trial

Novartis says it is suspending branapalm dosing in a Phase 2b trial of the drug in adults with Huntingtons Disease due to side effects seen in a data ...

latest-news-card-1
Biologics

Iovance Biotherapeutics BLA for Melanoma Therapy

Iovance Biotherapeutics initiates a rolling BLA for lifileucel, a tumor infiltrating lymphocyte therapy for use in patients with advanced (unresectabl...